The influence of glucocorticoid signaling on tumor progression

Brain, Behavior, and Immunity

Volumn 30, Issue SUPPL., 2013, Pages

  Volden, Paul A ^a   Conzen, Suzanne D ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Animal models; Breast cancer; Cortisol; Glucocorticoid receptor; Glucocorticoids; Social environment; Stress response

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; HORMONE ACTION; HUMAN; HYDROCORTISONE RELEASE; INTRACELLULAR SIGNALING; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN CANCER; TUMOR MICROENVIRONMENT;

ANIMALS; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; NEOPLASMS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84875370663     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.10.022     Document Type: Review

References (41)

1. Adzic M., Djordievic J., Djordievic A., Niciforovic A., Demonacos C., Radojcic M., Krstic-Demonacos M. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J. Endocrinol. 2009, 202:87-97.
2. Andersen B.L., Yang H.C., Farrar W.B., Golden-Kreutz D.M., Emery C.F., Thornton L.M., Young D.C., Carson W.E. Psychologic intervention improves survival for breast cancer patients a randomized clinical trial. Cancer 2008, 113:3450-3458.
3. Armaiz-Pena G.N., Lutgendorf S.K., Cole S.W., Sood A.K. Neuroendocrine modulation of cancer progression. Brain Behav. Immun. 2009, 23:10-15.
4. Black P.H., Garbutt L.D. Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 2002, 52:1-23.
5. Cao L., Liu X.L., Lin E.J.D., Wang C.S., Choi E.Y., Riban V., Lin B., During M.J. Environmental and genetic activation of a brain-adipocyte BDNF/Leptin axis causes cancer remission and inhibition. Cell 2010, 142:52-64.
6. Chung S., Son G.H., Kim K. Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochim. Biophys. Acta-Mol. Basis Dis. 2011, 1812.
7. Costanzo E.S., Sood A.K., Lutgendorf S.K. Biobehavioral influences on cancer progression. Immunol. Allergy Clin. North Am. 2011, 31:109.
8. Dallman M.F., Pecoraro N.C., la Fleur S.E. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav. Immun. 2005, 19:275-280.
9. Dedert E., Lush E., Chagpar A., Dhabhar F.S., Segerstrom S.C., Spiegel D., Dayyat E., Daup M., McMasters K., Sephton S.E. Stress, coping, and circadian disruption among women awaiting breast cancer surgery. Ann. Behav. Med. 2012, 44.
10. Draper N., Stewart P.M. 11 Beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J. Endocrinol. 2005, 186:251-271.
11. Duma D., Jewell C.M., Cidlowski J.A. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 2006, 102:11-21.
12. Finak G., Bertos N., Pepin F., Sadekova S., Souleimanova M., Zhao H., Chen H., Omeroglu G., Meterissian S., Omeroglu A., Hallett M., Park M. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 2008, 14.
13. Finger B.C., Dinan T.G., Cryan J.F. High-fat diet selectively protects against the effects of chronic social stress in the mouse. Neuroscience 2011, 192:351-360.
14. Gehlert S., Murray A., Sohmer D., McClintock M., Conzen S., Olopade O. The importance of transdisciplinary collaborations for understanding and resolving health disparities. Soc. Work Public Health 2010, 25:408-422.
15. Gong H., Jarzynka M.J., Cole T.J., Lee J.H., Wada T., Zhang B., Gao J., Song W.-C., DeFranco D.B., Cheng S.-Y., Xie W. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res. 2008, 68:7386-7393.
16. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
17. Hermes G.L., Delgado B., Tretiakova M., Cavigelli S.A., Krausz T., Conzen S.D., McClintock M.K. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc. Natl. Acad. Sci. USA 2009, 106:22393-22398.
18. Herr I., Pfitzenmaier J. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol. 2006, 7:425-430.
19. Herr I., Ucur E., Herzer K., Okouoyo S., Ridder R., Krammer P.H., Doeberitz M.V., Debatin K.M. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res. 2003, 63:3112-3120.
20. Hidalgo A.A., Montecinos V.P., Paredes R., Godoy A.S., McNerney E.M., Tovar H., Pantoja D., Johnson C., Trump D., Onate S.A. Biochemical characterization of nuclear receptors for vitamin D(3) and glucocorticoids in prostate stroma cell microenvironment. Biochem. Biophys. Res. Commun. 2011, 412:13-19.
21. Huang Y., Johnson K.R., Norris J.S., Fan W.M. Nuclear Factor-kappa B/I kappa B signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res. 2000, 60:4426-4432.
22. Kaidar-Person O., Bar-Sela G., Person B. The two major epidemics of the twenty-first century: obesity and cancer. Obes. Surg. 2011, 21:1792-1797.
23. Kissane D.W., Grabsch B., Clarke D.M., Smith G.C., Love A.W., Bloch S., Snyder R.D., Li Y. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology 2007, 16:277-286.
24. Lewis-Tuffin L.J., Cidlowski J.A. The physiology of human glucocorticoid receptor beta (hGR beta) and glucocorticoid resistance. Basic Clin. Aspects Neuroendocrine Immunol. Rheumatic Dis. 2006, 1069:1-9.
25. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature 2001, 411:375-379.
26. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
27. Melhem A., Yamada S.D., Fleming G.F., Delgado B., Brickley D.R., Wu W., Kocherginsky M., Conzen S.D. Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues. Clin. Cancer Res. 2009, 15:3196-3204.
28. Mikosz C.A., Brickley D.R., Sharkey M.S., Moran T.W., Conzen S.D. Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J. Biol. Chem. 2001, 276:16649-16654.
29. Moran T.J., Gray S., Mikosz C.A., Conzen S.D. The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res. 2000, 60:867-872.
30. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 2011, 286.
31. Pan D., Kocherginsky M., Conzen S.D. Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res. 2011, 71:6360-6370.
32. Park J., Euhus D.M., Scherer P.E. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr. Rev. 2011, 32:550-570.
33. Pecoraro N., Reyes F., Gomez F., Bhargava A., Dallman M.F. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 2004, 145:3754-3762.
34. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl Cancer Inst. 2000, 92:994-1000.
35. Smith R.A., Lea R.A., Weinstein S.R., Griffiths L.R. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma. Cancer Lett. 2007, 255:77-84.
36. Spiegel D., Butler L.D., Giese-Davis J., Koopman C., Miller E., DiMiceli S., Classen C.C., Fobair P., Carlson R.W., Kraemer H.C. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer - a randomized prospective trial. Cancer 2007, 110:1130-1138.
37. Stojanovich L., Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmun. Rev. 2008, 7:209-213.
38. Wallis D.J., Hetherington M.M. Emotions and eating. Self-reported and experimentally induced changes in food intake under stress. Appetite 2009, 52:355-362.
39. Williams J.B., Pang D., Delgado B., Kocherginsky M., Tretiakova M., Krausz T., Pan D., He J., McClintock M.K., Conzen S.D. A model of gene-environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer Prev. Res. 2009, 2:850-861.
40. Wu W., Chaudhuri S., Brickley D.R., Pang D., Karrison T., Conzen S.D. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res. 2004, 64:1757-1764.
41. Zhang C., Wenger T., Mattern J., Ilea S., Frey C., Gutwein P., Altevogt P., Bodenmueller W., Gassler N., Schnabel P.A., Dienemann H., Marme A., Hohenfellner M., Haferkamp A., Pfitzenmaier J., Grone H.J., Kolb A., Buchler P., Buchler M.W., Friess H., Rittgen W., Edler L., Debatin K.M., Krammer P.H., Rutz H.P., Herr I. Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors. Cancer Biol. Ther. 2007, 6:278-287.